How Are Oncologists Managing Amivantamab Plus Lazertinib in EGFR- Mutant NSCLC?
Oncology News Central Peer-Spectives · Oncololgy News Central
October 2, 202615m 5s
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.